Overview

Efficacy and Safety of LAS41003 in the Treatment of Inflammatory Tinea Pedis

Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to determine the efficacy and safety of a topical application of the combinational cream LAS41003 compared to application of its mono-substances after once daily treatment in patients with inflammatory tinea pedis.
Phase:
Phase 2
Details
Lead Sponsor:
Almirall, S.A.